Home › Funds › NewEdge Wealth, LLC › GILD

NewEdge Wealth, LLC position in GILD

GILEAD SCIENCES INC · Health Care

NewEdge Wealth, LLC reported holding 754,019 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$95.3M, representing 1.07% of its reported portfolio and ranking #14 among its reported holdings. NewEdge Wealth, LLC has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)754.02K sh
Reported value held$95.26M
Portfolio Weight1.07%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How NewEdge Wealth, LLC's GILD position evolved

NewEdge Wealth, LLC first disclosed a stake in GILD in Q3 2023 at 312,395 shares (US$23.4M). The position peaked in Q1 2026 at 706,725 shares, worth US$98.5M. Across 12 filings, NewEdge Wealth, LLC increased the stake 10 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 754,019 shares valued at US$95.3M — an increase of 47,294 shares quarter over quarter.. Notable position changes include a 39% increase in Q2 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 312.39K $23.41M New
Q4 2023 339.97K $27.54M Add
Q1 2024 377.43K $24.66M Add
Q2 2024 370.49K $25.42M Reduce
Q3 2024 374.57K $31.40M Add
Q4 2024 404.82K $37.39M Add
Q1 2025 432.24K $48.43M Add
Q2 2025 602.41K $66.43M Add
Q3 2025 619.69K $75.96M Add
Q4 2025 646.47K $79.35M Add
Q1 2026 706.73K $98.50M Add
Q2 2026 754.02K $95.26M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has NewEdge Wealth, LLC held GILD?

NewEdge Wealth, LLC has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is NewEdge Wealth, LLC's current position in GILD?

As of Q2 2026, NewEdge Wealth, LLC holds 754.02K shares of GILD (GILEAD SCIENCES INC), valued at $95.26M, representing 1.07% of its reported portfolio and ranking #14.

Has NewEdge Wealth, LLC been buying or selling GILD?

In the latest 13F filing (Q2 2026), NewEdge Wealth, LLC increased its position in GILD. The position peaked in Q1 2026 at 706.73K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.